The European Union cross-border healthcare market is projected to grow from USD 63 billion in 2025 to USD 137.4 billion by 2035, advancing at a CAGR of 8.1%. The industry is witnessing rising demand for interoperable care systems, elective procedure migration, and access to rare treatment pathways unavailable domestically.
In 2024, Swedish patients traveled to Denmark for advanced insulin pump therapies under specialized pediatric endocrinology programs at Steno Diabetes Center Copenhagen, circumventing six-month domestic waitlists (Source: Danish Ministry of Health).
In addition, Polish oncology patients were treated with CAR-T cell therapies at the Gustave Roussy Institute in France, which saw cross-border prioritization accept patients post-trial (Source: Institut National du Cancer).
In Portugal, elderly German citizens find themselves attracted to orthopedic joint replacement procedures offered by private hospitals in Lisbon and Porto at an attractive price with the EHIC (Source: Serviço Nacional de Saúde).
The trend toward a patient-centered focus is mirrored in the evolution of the EU's proposals, which seeks to facilitate fair access for all member states through patient mobility, harmonization of health technologies, and the development of specialized centers of excellence throughout different regions.
Market Overview
| Attribute | Value |
|---|---|
| Estimated EU Cross-Border Healthcare Market Size (2025E) | USD 63 billion |
| Projected Value (2035F) | USD 137.4 billion |
| CAGR (2025 to 2035) | 8.1% |
Explore FMI!
Book a free demo
By 2025, surging outbound patient flows for oncology, fertility, and musculoskeletal services are fueling intra-EU medical travel. Countries with efficient reimbursement claims and ePrescription interoperability-such as Belgium, Germany, and the Netherlands-are leading outbound patient mobility (Source: European Commission - Cross-Border Healthcare Reports).
| Category | Details |
|---|---|
| Market Value (2024) | USD 58.4 billion |
| Leading Destinations | Germany, France, Spain, Hungary, Czechia |
| Key Drivers | Elective procedure migration, specialty access gaps, fertility tourism, digital interoperability |
| Economic Impact | Supports ~850,000 direct jobs in EU’s healthcare and allied sectors (Source: European Observatory on H ealth Systems and Policies ) |
| Top Specialties | Oncology, Reproductive Health, Orthopedics, Dentistry, Neurology |
| Travel Flow Trends | Peak periods: January-March (post-holiday care), June-September (elective summer surgeries) |
| Year | Age 18-45 (% ) : Age Over 45 (%) |
|---|---|
| 2024 | 36.4% : 63.6% |
| 2025 Est. | 39.9% : 60.1% |
Younger adults increasingly seek affordable fertility treatment options outside their home countries. For instance, Danish couples frequently travel to Spain’s Basque region to access IVF with donor eggs due to broader legal access and shorter waiting times (Source: Spanish Fertility Society).
Besides, retirees from Finland and Austria continue to dominate orthopedic medical travel-preferring Czechia’s Karlovy Vary for its bundled hip and knee replacement packages combined with spa rehabilitation (Source: Czech Ministry of Health).
| Date | Development & Details |
|---|---|
| Jan 2025 | EU launches Digital Health Passport 2.0 to enable seamless medical records sharing across 22 member states (Source: European Health Data Space ) |
| Dec 2024 | France expands bilateral oncology treatment access to include Belgian and Luxembourg patients (Sou rce: Ministère de la Santé ) |
| Nov 2024 | Hungarian dental tourism clusters integrate robotic-assisted procedures into cross-border offerings (Source: Universit y of Szeged Dental Faculty ) |
| Oct 2024 | Germany initiates a pilot for AI-based second opinion protocols available to Polish and Czech patients in neurodegenerative diagnostics (Source: Charité - Universitätsmedizin Berlin ) |
| Sept 2024 | Slovakia partners with Italy on co-managed fertility clinics for underserved EU populations (Source: Slo vak Academy of Sciences ) |
Advanced Specialty Access Drives Cross-Border Patient Mobility
Cross-border patient mobility in the EU is increasingly defined by access to high-specialty treatments unavailable or delayed in patients' home countries. As of 2025, over 61% of EU cross-border healthcare expenditure goes toward advanced specialties such as oncology, fertility care, and neurology.
For instance, Dutch glioblastoma patients now regularly travel to France’s Centre Léon Bérard in Lyon to undergo individualized immunotherapy protocols under early-access compassionate use programs (Source: European Medicines Agency, 2024).
These treatments remain inaccessible in the Netherlands due to regulatory lag and cost barriers. Similarly, Slovak patients with advanced breast cancer seek HER2-low targeted therapies in Germany’s University Hospital Heidelberg, which boasts real-time tumor sequencing integrated into patient care (Source: DeutschesKrebsforschungszentrum).
On the fertility front, Estonian couples bypass national age restrictions by accessing egg donation cycles in Czechia’s Brno-based Reprofit International, which maintains one of the EU's largest donor databases and offers legally protected anonymity (Source: Czech Ministry of Health, 2024).
Meanwhile, Irish patients with treatment-resistant epilepsy are now traveling to Spain’s Clínica Universidad de Navarra, where deep brain stimulation surgeries are performed by bilingual neurosurgery teams under joint funding programs between national insurers and EU cross-border health grants.
Moreover, orthopedic patients from Belgium are opting for fast-track anterior hip replacement surgeries in Lithuania’s Kaunas Clinics, where same-week surgery scheduling, robotic assistance, and bundled post-op physical therapy create a streamlined care pathway (Source: Hospital Performance Review Network, 2024). These centers also offer remote recovery support via tele-physiotherapy in Dutch and French.
In essence, the EU's evolving healthcare mobility reflects a pattern: patients actively seek competence, speed, and specialization. As digital pre-authorizations and multilingual teleconsultations become the norm, Europe’s leading centers of excellence now operate as regional medical hubs-drawing patients not just for treatment, but for integrated, outcome-driven care ecosystems.
Group Medical Travel Expands for Rehabilitation and Wellness
Group medical travel has evolved beyond wellness getaways into a core pillar of the EU’s cross-border healthcare model. By 2025, 28% of cross-border healthcare revenue stems from coordinated group treatments, especially in rehabilitation, chronic condition management, and long-term convalescence.
Swiss Parkinson’s patients increasingly join cohort-based neuromotor rehabilitation programs in Slovenia’s TermeDolenjskeToplice, where a consortium of neurologists and physiatrists runs six-week immersive recovery cycles. These programs include hydrotherapy, speech therapy, and non-pharmacological gait training, supported by EU structural health funds (Source: National Institute of Public Health Slovenia, 2024).
Likewise, Polish stroke survivors attend post-acute care retreats in Italy’s Emilia-Romagna region. There, neurorehabilitation specialists at Montecatone Rehabilitation Institute employ robotic exoskeleton-assisted mobility training. These patients also receive cognitive therapy in Polish, facilitated by translator-clinicians hired under the EU’s “CrossMed Lingua” initiative (Source: European Social Fund Plus, 2024).
In another example, Hungarian cardiac patients travel in organized groups to Romania’s BaileHerculane, where climate-adapted cardiovascular recovery includes thermal water-based vasodilation therapy, stress coaching, and 24/7 medical supervision. Packages often include mobile ECG monitoring and nutritional counseling for post-surgical patients on statin regimens (Source: Romanian Health Promotion Authority, 2024).
Germany’s largest osteoarthritis association now collaborates with Czech hospitals to offer “joint wellness residencies” for retirees. These three-week orthopedic residencies combine personalized hydrokinetic regimens with evidence-based pain education and multilingual community-building sessions-a crucial element for reducing post-treatment isolation (Source: Czech Balneological Research Institute, 2024).
Notably, these group programs are no longer designed solely for affordability. They promote psychological resilience, community-based recovery, and culturally sensitive care. Operators like CareWay Mobility Services and SalusConnect now structure entire journeys-from transport and therapy schedules to digital discharge summaries-optimizing continuity, compliance, and comfort for diverse patient cohorts.
Germany remains Europe’s largest source of outbound healthcare seekers. In 2024, over 720,000 German patients received medical treatment abroad (Source: German Federal Ministry of Health). In 2025, this number is projected to rise, driven by elevated wait times and increasing demand for niche reproductive and rehabilitation services.
German couples now travel to Greece’s Thessaloniki IVF centers for egg donation treatments not permissible under domestic law (Source: Hellenic Society of Reproductive Medicine). Meanwhile, stroke rehabilitation programs in Poland’s Kraków attract German patients seeking faster access and intensive neuroplasticity therapies (Source: Medical University of Kraków).
Additionally, high-income German retirees book dental implants and full-arch restoration services in Malta under all-inclusive surgical tourism schemes.With Germany’s advanced health insurance portability under the EU Patient Rights Directive, cross-border elective care is expected to grow at a 7.4% CAGR through 2035.
France’s patient mobility is guided by diaspora needs, affordability differentials, and access to minimally invasive treatments. In 2024, nearly 370,000 French citizens sought treatment abroad, a figure expected to reach 520,000 by 2035 (Source: Haute Autorité de Santé).
In 2025, French endometriosis patients increasingly seek laparoscopic excision surgeries in Belgium, where procedural wait times are half as long and postoperative outcomes are monitored via EUHASS registries (Source: UniversitéLibre de Bruxelles).
French retirees also travel to Portugal for rheumatology-focused hydrotherapy retreats under structured insurance reimbursements.Boutique firms such as MediEurope Routes now offer bundled diagnostics, surgery, and recovery services in central and southern Europe, reflecting France’s expanding appetite for curated medical itineraries rooted in affordability and therapeutic excellence.
The EU cross-border healthcare landscape is increasingly shaped by firms and institutions that combine precision medicine, multilingual logistics, and cultural adaptation. While state-level agreements still underpin most mobility flows, specialized brokers and care operators are redefining how patients plan and experience healthcare abroad.
| Provider | Specialty Area |
|---|---|
| MediBridge Europe | Oncology Access Pathways |
| SalusConnect | Post-Op Continuity and Rehabilitation |
| ClinRoute | Fertility Tourism and IVF Legal Navigation |
| CareWay Mobility Services | Group Medical Travel and Chronic Rehab |
(Source: European Patients’ Forum)
The market is expected to grow at 8.1% CAGR over the forecast period.
It is projected to reach USD 137.4 billion by 2035.
Key drivers include elective procedure wait times, specialty access gaps, regulatory harmonization, and expanded digital health interoperability.
Notable providers include MediBridge Europe, SalusConnect, ClinRoute, and CareWay Mobility Services-each excelling in patient-centered cross-border treatment coordination.
Industrial Tourism Market Analysis by Experience Type, by End, by Tourist, by Booking Channel, and by Region - Forecast for 2025 to 2035
China Outbound MICE Tourism to US Market 2025 to 2035
Responsible Tourism Market Analysis – Trends, Growth & Forecast 2025 to 2035
Mountain and Snow Tourism Market Analysis – Trends, Growth & Forecast 2025 to 2035
Incentive Tourism Industry Analysis By Incentive Type, By Business Size, By End User, By Region – Forecast for 2025 to 2035
Cruise Tourism Industry Analysis By Cruise Type, By Experience Type, By End User (Solo Travelers, Families, Retirees, Business Travelers), By Region – Forecast for 2025 to 2035
European Union Cross-Border Healthcare Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
